Quick Answer
NEXGEL, INC. reported Operating Income Loss of -$3.35 million for the year ending 2025.
- NEXGEL, INC. showed an increase of +5.7% in Operating Income Loss from 2024 to 2025.
- This data is from NEXGEL, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: -$287.0 thousand | Q1 2019: -$612.0 thousand | Q2 2019: -$1.07 million | Q3 2019: $74.0 thousand | Q1 2020: -$509.0 thousand | Q2 2020: -$540.0 thousand | Q3 2020: -$535.0 thousand | Q1 2021: -$520.0 thousand | Q2 2021: -$553.0 thousand | Q3 2021: -$610.0 thousand | Q1 2022: -$812.0 thousand | Q2 2022: -$718.0 thousand | Q3 2022: -$1.04 million | Q1 2023: -$883.0 thousand | Q2 2023: -$762.0 thousand | Q3 2023: -$612.0 thousand | Q1 2024: -$871.0 thousand | Q2 2024: -$1.05 million | Q3 2024: -$788.0 thousand | Q1 2025: -$777.0 thousand | Q2 2025: -$636.0 thousand | Q3 2025: -$725.0 thousand.
- Over the full 8 years of available data (2018 to 2025), NEXGEL, INC.'s Operating Income Loss has declined by 77.5%.
- Historical annual values: Fiscal year 2025: -$3.35 million | Fiscal year 2024: -$3.55 million | Fiscal year 2023: -$3.48 million | Fiscal year 2022: -$3.35 million | Fiscal year 2021: -$2.57 million | Fiscal year 2020: -$2.26 million | Fiscal year 2019: -$1.92 million | Fiscal year 2018: -$1.89 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: